Search Results - "Cohen, V I"

Refine Results
  1. 1

    In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones by Cohen, Victor I, Jin, Biyun, McRee, R.Carter, Boulay, Sheila F, Cohen, Emil I, Sood, Virendar K, Zeeberg, Barry R, Reba, Richard C

    Published in Brain research (10-04-2000)
    “…Alzheimer's disease (AD) involves selective loss of muscarinic m2, but not m1, subtype receptors in cortical and hippocampal regions of the human brain…”
    Get full text
    Journal Article
  2. 2

    A novel m2-selective muscarinic antagonist: binding characteristics and autoradiographic distribution in rat brain by Gitler, M S, Reba, R C, Cohen, V I, Rzeszotarski, W J, Jin, B, Baumgold, J

    Published in Brain research (12-06-1992)
    “…Although several m2-selective muscarinic antagonists have been described, they are not particularly potent. Thus, the development of potent m2-selective…”
    Get more information
    Journal Article
  3. 3

    In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT by Cohen, V I, Zeeberg, B R, Boulay, S F, Sood, V K, Rayeq, M R, Danesh, R A, McPherson, D W, Reba, R C

    Published in Journal of molecular neuroscience (01-08-1998)
    “…Alzheimer's disease (AD) involves selective loss of muscarinic m2, but not m1, subtype neuroreceptors in cortical and hippocampal regions of the human brain…”
    Get full text
    Journal Article
  4. 4

    A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtype by Gitler, M S, Cohen, V I, De la Cruz, R, Boulay, S F, Jin, B, Zeeberg, B R, Reba, R C

    Published in Life sciences (1973) (1993)
    “…Alzheimer's disease (AD) involves selective loss of muscarinic m2, but not m1, subtype neuroreceptors in the posterior parietal cortex of the human brain…”
    Get more information
    Journal Article
  5. 5

    Specific binding component of the “inactive” stereoisomer (S,S)-[ 125I]IQNB to rat brain muscarinic receptors in vivo by Boulay, Sheila F., McRee, R.Carter, Cohen, Victor I., Sood, Virendar K., Zeeberg, Barry R., Reba, Richard C.

    Published in Nuclear medicine and biology (01-04-1996)
    “…In vivo nonspecific binding can be estimated using the inactive stereoisomer of a receptor radioligand. However, the binding of the inactive stereoisomer may…”
    Get full text
    Journal Article
  6. 6

    Muscarinic receptor subtype selectivity of novel heterocyclic QNB analogues by Baumgold, J, Cohen, V I, Paek, R, Reba, R C

    Published in Life sciences (1973) (1991)
    “…In an effort at synthesizing centrally-active subtype-selective antimuscarinic agents, we derivatized QNB (quinuclidinyl benzilate), a potent muscarinic…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Synthesis and structure-activity relationships of new muscarinic antagonists by Cohen, V I, Gibson, R E, Reba, R C

    Published in Journal of pharmaceutical sciences (01-10-1987)
    “…In an attempt to develop more selective muscarinic acetylcholine receptor (m-AcChR) antagonists, (R)-1-azabicyclo[2.2.2]oct-3-yl-thioxanthene-9-carboxylate,…”
    Get more information
    Journal Article
  9. 9

    Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtype by Boulay, S F, Sood, V K, Rayeq, M R, Cohen, V I, Zeeberg, B R, Reba, R C

    Published in NeuroImage (Orlando, Fla.) (01-02-1996)
    “…Alzheimer's disease (AD) involves selective loss of muscarinic m2, but not m1, subtype neuroreceptors in cortical and hippocampal regions of the human brain…”
    Get full text
    Journal Article
  10. 10

    Autoradiographic Evidence That QNB Displays in Vivo Selectivity for the m2 Subtype by McRee, R.C., Boulay, S.F., Sood, V.K., Cohen, E.I., Cohen, V.I., Gitler, M.S., Zeeberg, B.R., Gibson, R.E., Reba, R.C.

    Published in NeuroImage (Orlando, Fla.) (01-03-1995)
    “…Alzheimer's disease (AD) involves selective loss of muscarinic m2, but not m1, subtype neuroreceptors in cortical and hippocampal regions of the human brain…”
    Get full text
    Journal Article
  11. 11

    Synthesis and structure-activity relationship of some 5-[[(dialkylamino)alkyl]-1-piperidinyl]acetyl]-10,11-dihydro-5H-benzo[b,e][1,4]diazepin-11-ones as M2-selective antimuscarinics by COHEN, V. I, BAUMGOLD, J, JIN, B, DE LA CRUZ, R, RZESZOTARSKI, W. J, REBA, R. C

    Published in Journal of medicinal chemistry (08-01-1993)
    “…A series of 5-[[[(dialkylamino)alkyl]-1-piperidinyl]acetyl]- 10,11-dihydro-5H-dibenzo[b,e][1,4]-diazepin-11-ones were prepared as potential M2-selective…”
    Get full text
    Journal Article
  12. 12

    Autoradiographic Evidence That Quinuclidinyl 4-(Bromophenyl)-2-thienylglycolate (QBPTG) Displays in Vivo Selectivity for the Muscarinic m2 Subtype by Boulay, S.F., Sood, V.K., Rayeq, M.R., McRee, R.C., Cohen, E.I., Cohen, V.I., Zeeberg, B.R., Reba, R.C.

    Published in NeuroImage (Orlando, Fla.) (01-09-1995)
    “…Alzheimer's disease (AD) involves selective loss of muscarinic m2, but not m1, subtype neuroreceptors in cortical and hippocampal regions of the human brain…”
    Get full text
    Journal Article
  13. 13
  14. 14

    In Vitro and In Vivo Characteristics of [Iodine-125] 3-(R)-Quinuclidinyl (S)-4-Iodobenzilate by Gibson, Raymond E, Schneidau, Timothy A, Cohen, Victor I, Sood, Virendar, Ruch, Jennifer, Melograna, John, Eckelman, William C, Reba, Richard C

    Published in The Journal of nuclear medicine (1978) (01-06-1989)
    “…The radioiodinated muscarinic acetylcholine receptor antagonist, [125I] 3-quinuclidinyl 4-iodobenzilate, has two high affinity diastereomeric forms, the (R,R)…”
    Get full text
    Journal Article
  15. 15

    Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype composition by Boulay, S F, Gitler, M S, Sood, V K, Cohen, V I, Zeeberg, B R, Reba, R C

    Published in Receptor (1995)
    “…We have used the dissection of selected rat brain regions to compare the in vivo pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB…”
    Get more information
    Journal Article
  16. 16

    Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl .alpha.-(alkoxyalkyl)-.alpha.-aryl-.alpha.-hydroxyacetates by Cohen, Victor I, Gibson, Raymond E, Fan, Linda H, De la Cruz, Rosanna, Gitler, Miriam S, Hariman, Erin, Reba, Richard C

    Published in Journal of medicinal chemistry (01-10-1991)
    “…Seven analogues of 3-quinuclidinyl benzilate (QNB) in which one phenyl ring was replaced by an alkoxyalkyl moiety were synthesized and their affinities for the…”
    Get full text
    Journal Article
  17. 17

    Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain by Makunts, Tigran, Cohen, Isaac V, Lee, Kelly C, Abagyan, Ruben

    Published in PloS one (18-04-2018)
    “…Currently approved monoamine modulating antidepressant and anxiolytic pharmaceutics fail in over one third of patients due to delayed and variable therapeutic…”
    Get full text
    Journal Article
  18. 18

    Synthesis and receptor affinities of new 3-quinuclidinyl alpha-heteroaryl-alpha-aryl-alpha-hydroxyacetates by Cohen, V I, Gibson, R E, Fan, L H, de la Cruz, R, Gitler, M S, Hariman, E, Reba, R C

    Published in Journal of pharmaceutical sciences (01-04-1992)
    “…Five analogues of 3-quinuclidinyl benzilate were prepared in which one phenyl ring was substituted by a heterocycle; a bromine was included on either the…”
    Get more information
    Journal Article
  19. 19

    Molecular modeling of the interaction of diagnostic radiopharmaceuticals with receptor proteins: m2 antagonist binding to the muscarinic m2 subtype receptor by Kapp, O H, Siemion, J, Eckelman, W C, Cohen, V I, Reba, R C

    Published in Receptors & signal transduction (1997)
    “…Models of the m2 muscarinic receptor have been built and acetylcholine and an antagonist of the quinuclidinyl benzilate family docked to the putative active…”
    Get more information
    Journal Article
  20. 20

    Acetaminophen (Paracetamol) Use Modifies the Sulfation of Sex Hormones by Cohen, Isaac V., Cirulli, Elizabeth T., Mitchell, Matthew W., Jonsson, Thomas J., Yu, James, Shah, Naisha, Spector, Tim D., Guo, Lining, Venter, J. Craig, Telenti, Amalio

    Published in EBioMedicine (01-02-2018)
    “…Acetaminophen (paracetamol) is one of the most common medications used for management of pain in the world. There is lack of consensus about the mechanism of…”
    Get full text
    Journal Article